ADA guidelines recommend GLP-1 agonists as preferred second-line agents for patients with established atherosclerotic cardiovascular disease
Whilst it is not as well-established as the other treatments mentioned in this review, primarily due to its inconsistent efficacy, immunotherapy methods have become increasingly popular avenues for exploration and have even had some clinical success (Bates et al., 2018
Clinicians administer the peptides through subcutaneous injections because this method provides consistent growth hormone release
This review highlights recent advances in the endometrial research domain, focusing on endometrial epithelial organoid models that closely replicate the cellular, transcriptomic and functional characteristics of the native tissue
Comparison of the results with the actual values of the large intestine of normal mice revealed that the large intestine of the Con-DSS group was significantly atrophied due to inflammation on the 3rd day after DSS administration (Fig
Several possibilities exist